Friday, October 16, 2015

Catalyst combining reactivity, selectivity could speed drug development

Chemists have long believed that inserting nitrogen -- a beneficial ingredient for making many pharmaceuticals and other biologically active molecules -- into a carbon-hydrogen bond requires a trade-off between catalyst reactivity and selectivity. But a new manganese-based catalyst has given researchers both in one efficient, lower-cost package.

from Geochemistry News -- ScienceDaily http://ift.tt/1Mu9Krr
via IFTTT

No comments:

Post a Comment